Abiopharma

Retirement Of Mr. Lee Keck Keong As Executive Director

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

InnovAge PACE Sponsors Documentary Spotlighting National Crisis in Family Caregiving

EPAM Systems, Inc. - EPAM Releases DIAL 3.0: An Evolution of Open-Source GenAI Enterprise Platform

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Sellas Life Sciences - SELLAS Life Sciences to be Added to Russell3000® and Russell 2000® Indexes

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

Semler Scientific® Announces CardioVanta™,a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities

New Form 8-K - OneMedNet Corp Filed: 2025-06-24 AccNo: 0001641172-25-016223 Size: 833 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - ImmunoPrecise Antibodies Ltd. Filed: 2025-06-24 AccNo: 0000950170-25-089224 Size: 64 KB

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives

New Form 8-K - BIO-PATH HOLDINGS, INC. Filed: 2025-06-24 AccNo: 0001558370-25-008814 Size: 148 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events